Literature DB >> 10353622

In vitro and in vivo alterations of enzymatic glycosylation in diabetes.

N Rellier1, D Ruggiero-Lopez, M Lecomte, M Lagarde, N Wiernsperger.   

Abstract

Carbohydrate composition changes of glycoconjugates constituting the glycocalix of microvascular cells could be involved in the alterations of cell-cell interactions observed in diabetic retinopathy. In this field, we have recently reported that advanced glycation end products (AGEs) modify galactose, fucose and sialic acid contents of specific cellular glycoproteins. To better understand the mechanisms involved in glycoprotein modifications in diabetes, we now investigate whether glucose and AGEs could affect the activities of enzymes involved in galactose, fucose and sialic acid metabolism : glycosyltransferases (synthesis) and glycosidases (catabolism). For this, bovine retinal endothelial cells (BREC) and pericytes (BRP) were cultured in the presence of high glucose concentration or AGEs, and cell glycosidase and glycosyltransferase activities were measured. The same enzymatic activities were studied in the whole retina from streptozotocin-treated rats. The results show that high glucose concentration did not affect glycosidases and glycosyltransferases neither in BRP nor in BREC except for galactosyltransferase activities in BREC. Concerning BRP, only galactosyltransferase activities were altered by AGEs. In contrast, in BREC, AGEs increased beta-D galactosidase, alpha-L fucosidase and neuraminidase activities (+37%, +56%, 36% respectively) whereas galactosyltransferase, fucosyltransferase and sialyltransferase activities were decreased (-11%, -24% and -23% respectively). In the retina from diabetic rats, beta-D galactosidase, alpha-L fucosidase and neuraminidase activities increased (+70%, +57%, +78% respectively) whereas fucosyl and sialyltransferase decreased (-7% and -15% respectively). The possible consequence of these enzymatic activity changes could be a defect in the carbohydrate content of some glycoproteins that might participate in the endothelial cell dysfunctions in diabetic microangiopathy.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10353622     DOI: 10.1016/s0024-3205(99)00094-6

Source DB:  PubMed          Journal:  Life Sci        ISSN: 0024-3205            Impact factor:   5.037


  7 in total

1.  Effect of Tungstate Administration on the Lipid Peroxidation and Antioxidant Parameters in Salivary Glands of STZ-Induced Diabetic Rats.

Authors:  Douglas Nesadal de Souza; Eugen Mendes Nesadal de Souza; Marlus da Silva Pedrosa; Fernando Neves Nogueira; Alyne Simões; José Nicolau
Journal:  Biol Trace Elem Res       Date:  2020-06-29       Impact factor: 3.738

2.  Post-translational modification regulates prostaglandin D2 synthase apoptotic activity: characterization by site-directed mutagenesis.

Authors:  Louis Ragolia; Christopher E Hall; Thomas Palaia
Journal:  Prostaglandins Other Lipid Mediat       Date:  2006-11-07       Impact factor: 3.072

3.  Significance of serum and urine neuraminidase activity and serum and urine level of sialic acid in diabetic nephropathy.

Authors:  Jamshid Roozbeh; Ahmad Merat; Farahnaz Bodagkhan; Raha Afshariani; Hooman Yarmohammadi
Journal:  Int Urol Nephrol       Date:  2011-01-05       Impact factor: 2.370

4.  Cooperative roles of glucose and asparagine-linked glycosylation in T-type calcium channel expression.

Authors:  Joanna Lazniewska; Yuriy Rzhepetskyy; Fang-Xiong Zhang; Gerald W Zamponi; Norbert Weiss
Journal:  Pflugers Arch       Date:  2016-09-23       Impact factor: 3.657

5.  The Inhibitory Role of α2,6-Sialylation in Adipogenesis.

Authors:  Tomoko Kaburagi; Yasuhiko Kizuka; Shinobu Kitazume; Naoyuki Taniguchi
Journal:  J Biol Chem       Date:  2016-12-28       Impact factor: 5.157

6.  Serum level of sialic acid (SA) and carbohydrate-deficient transferrin (CDT) in type 2 diabetes mellitus with microvascular complications.

Authors:  Bogdan Cylwik; Lech Chrostek; Barbara Jakimiuk; Anna Popławska; Maciej Szmitkowski
Journal:  J Clin Lab Anal       Date:  2006       Impact factor: 2.352

7.  Glycosylation failure extends to glycoproteins in gestational diabetes mellitus: evidence from reduced α2-6 sialylation and impaired immunomodulatory activities of pregnancy-related glycodelin-A.

Authors:  Cheuk-Lun Lee; Philip C N Chiu; Poh-Choo Pang; Ivan K Chu; Kai-Fai Lee; Riitta Koistinen; Hannu Koistinen; Markku Seppälä; Howard R Morris; Bérangère Tissot; Maria Panico; Anne Dell; William S B Yeung
Journal:  Diabetes       Date:  2011-02-07       Impact factor: 9.461

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.